Hamlet BioPharma Balance Sheet Health
Financial Health criteria checks 4/6
Hamlet BioPharma has a total shareholder equity of SEK54.2M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK59.3M and SEK5.1M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 16.54m |
| Equity | SEK 54.19m |
| Total liabilities | SEK 5.12m |
| Total assets | SEK 59.31m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7ZT's short term assets (SEK20.7M) exceed its short term liabilities (SEK5.1M).
Long Term Liabilities: 7ZT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 7ZT is debt free.
Reducing Debt: 7ZT had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7ZT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 7ZT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 15.9% each year